Solventum Corporation SOLV
NYSE · Healthcare · Medical - Instruments & Supplies
$84.50
Close on Fri, 20 Nov 2026 · market value $14.4B
No single growth bet
Solventum Corporation is valued on the income it pays out or on its book, not on one rate of revenue growth, so its price doesn't reduce to a single bet. The three stories below still show what it could be worth.
Both sides
Three stories, three values
Bear
$2.86
Base
$2.89
Bull
$2.92
Today $85
- Bear $2.86. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $2.89. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $2.92. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
At a glance
Healthcare · Medical - Instruments & Supplies · listed on NYSE
- Revenue, FY2025
- $8.3B
- Growth, 3 years a year
- −0.2%
- Cash margin
- −0.1%
- Net debt
- $4.2B
- Shares, 3-year change
- +1.6%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.